These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8811647)

  • 1. Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.
    Moll H; Ritter U; Flohé S; Erb K; Bauer C; Blank C
    Med Microbiol Immunol; 1996 Feb; 184(4):163-8. PubMed ID: 8811647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
    Moll H
    Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis.
    Moll H
    Immunol Today; 1993 Aug; 14(8):383-7. PubMed ID: 8397776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
    Will A; Blank C; Röllinghoff M; Moll H
    Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemokines in regulation of immunity against leishmaniasis.
    Oghumu S; Lezama-Dávila CM; Isaac-Márquez AP; Satoskar AR
    Exp Parasitol; 2010 Nov; 126(3):389-96. PubMed ID: 20206625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis.
    Okwor I; Uzonna JE
    Cell Immunol; 2016 Nov; 309():32-36. PubMed ID: 27394077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
    de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
    Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leishmaniasis: principles of the immune response and function of nitric oxide].
    Bogdan C
    Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):409-14. PubMed ID: 9880934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
    Moll H; Fuchs H; Blank C; Röllinghoff M
    Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin dendritic cells in murine cutaneous leishmaniasis.
    Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y
    Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host susceptibility factors to cutaneous leishmaniasis.
    Jones DE; Elloso MM; Scott P
    Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human immune response during cutaneous leishmaniasis: NO problem.
    Mossalayi MD; Arock M; Mazier D; Vincendeau P; Vouldoukis I
    Parasitol Today; 1999 Aug; 15(8):342-5. PubMed ID: 10407383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania major.
    ElHassan AM; Gaafar A; Theander TG
    Clin Exp Immunol; 1995 Mar; 99(3):445-53. PubMed ID: 7882568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by epidermal Langerhans cells in experimental cutaneous leishmaniasis.
    Axelrod O; Klaus S; Frankenburg S
    Parasite Immunol; 1994 Nov; 16(11):593-8. PubMed ID: 7862465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
    Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
    J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.
    Mandell MA; Beverley SM
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E801-E810. PubMed ID: 28096392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.